INS and metabolic dysfunction-associated steatotic liver disease: In NAFLD, fatty acids accumulate in hepatocytes and reduce hepatic insulin sensitivity, thereby promoting hepatic gluconeogenesis, thereby increasing the risk of type 2 diabetes (T2D) or exacerbating disease pathology in diabetic patients (25, 26).